Markets

DexCom Announces Availability Of Dexcom G7 15 Day Continuous Glucose Monitoring System In Canada From November

Oct 28, 2026 · 08:17 AM ET· updated 2h ago

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) will be available in Canada beginning next month for adults 18

Why It Matters

DexCom's glucose monitoring device is now available in Canada. This expands where the company can sell its product and reach more customers.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

DXCM78.86

+0.30 (+0.38%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.